ATMP News and Events

What are the Differences in the Requirements for Cell and Gene Therapy between the FDA and EMA?

Continue Reading
St James Hospital in Dublin starts the first CAR-T therapy trial for myeloma patients

Dublin’s St James Hospital Opens the First Trial to Treat Patients with Car-T Immunotherapy

Continue Reading

Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer

Continue Reading
Solupore clinical manufacturing system for non-viral delivery to enable next- generation cell therapies.

Avectas Launches the Solupore® Platform at the Advanced Therapies Week in Miami

Continue Reading

A Novel Cell Therapy Shows Encouraging Results with Diabetes Type 2 Patients with Kidney Damage

Continue Reading
University College of Cork Futures - Future Medicines opens positions for researchers

UCC Future Medicines Opens Academic Posts for Researchers with a Disruptive and Transformational Focus

Continue Reading